Acepodia, Inc. (TPEX: 6976)
Health Care · Biotechnology · KY
NT$13.40
+4.69% today · -22.1% 1Y
Acepodia, Inc. (TPEX: 6976) operates in the Biotechnology industry within the Health Care sector. The company is valued at $244.38M and employs 20 people.
Over the last twelve months the share price has lost 22.1%, trading between 10.85 and 17.40.
Tweenvest scores Acepodia, Inc. across four factors: quality 42/100, value 48/100. Its strongest factor is value.
6976 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $244.38M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -1.42
- Dividend yield
- —
- Beta (5Y)
- 0.48
- 52-week high
- NT$17.40
- 52-week low
- NT$10.85
- Avg volume (3M)
- —
- Shares outstanding
- 583.13M
- Employees
- 20
- Next earnings
- —
About Acepodia, Inc.
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
- ISIN
- KYG0073G1091
- Listed since
- Aug 8, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AC Immune SANasdaqGM: ACIU | $248.57M | $2.50 | -8.26% |
| Racura Oncology LtdASX: RAC | $248.34M | AU$1.82 | -5.47% |
| Q32 Bio Inc.NasdaqCM: QTTB | $248.28M | $8.34 | +1.34% |
| Shandong Boan Biotechnology Co., Ltd.SEHK: 6955 | $245.84M | HK$3.10 | +2.31% |
| Oryzon Genomics S.A.BME: ORY | $243.20M | €2.65 | +0.76% |
| Polaris GroupTWSE: 6550 | $242.78M | NT$16.70 | -0.30% |
| Greenwich LifeSciences, Inc.NasdaqCM: GLSI | $242.63M | $16.53 | -2.65% |
| Pyxis Oncology, Inc.NasdaqGS: PYXS | $242.50M | $2.03 | -5.14% |
Figures last refreshed Oct 11, 2026.